Dr. Eric Leire, CEO of DanDrit Biotech, will be a Speaker September 22 at 13:30 Denmark Time

Copenhagen, Denmark, September 7, 2015 – DanDrit Biotech A/S (“DanDrit Denmark”), the subsidiary of DanDrit Biotech USA, Inc. (“DanDrit”), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, announced that its Chief Executive Officer, Dr. Eiric Leire, will be speaking at the the Investor Day in Copenhagen Tuesday, September 22, 2015 at the at the Radisson Blu Scandinavia Hotel, Amager Boulevard 70, 2300 Copenhagen S.

Dr.Leire noted, “This is an excellent opportunity to introduce the exciting developments ongoing at DanDrit as we pursue the development of our lead compound MCV, a colorectal cancer immunotherapy.

Our proprietary and patented approach using a patient’s own blood to develop a vaccine shows great promise and we will be making several announcements shortly discussing our continuing success.”

Contact: ir@enochianbio.com